Arno Therapeutics, Inc Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
Arno Therapeutics, Inc reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $20.52 million for the 12-month period ending 2012-12-31, per its 10-Q filed 2013-11-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2013-11-14
- Arno Therapeutics, Inc fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2011 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month as first filed |
|---|---|---|
| 2012-12-31 | $20.52M 10-Q · filed 2013-11-14 | $20.52M 10-K · filed 2013-04-01 |
| 2011-12-31 | $0.00 10-K · filed 2013-04-01 |